CareAcross provides personalised support services for patients with cancer. Their focus is on sharing research findings and guidelines, and offer evidence-based approaches to improve quality of life for those living with cancer, whilst strengthening the relationship between the patient and their medical team.
CareAcross engages with thousands of patients diagnosed with many different cancers, providing services around patient engagement, real world evidence, clinical trial recruitment, and patient-reported outcomes.
The relationship between a patient and their doctor is unique, especially when it is about cancer. CareAcross set out to identify the needs and priorities of patients regarding this critical aspect of their experience with cancer.
M3 regularly partners with CareAcross by giving their members the opportunity to take part in our research studies and share their opinion on existing, and future, oncological therapies.
We partnered with CareAcross on this survey which aims to understand the needs of patients affected by different types of cancer.

HFpEF rates rising as heart failure cases globally increase, while Journal of Cardiology highlights the diagnostic challenges.

Artificial intelligence reasoning model shows ai outperformed physicians in diagnosing complex clinical cases

Burnout in neurodivergent doctors rises as british medical association reports doctors were at high risk of burnout in 2022.